Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avicanna Inc (AVCN.TO)

Avicanna Inc (AVCN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 38,065
  • Shares Outstanding, K 97,602
  • Annual Sales, $ 16,791 K
  • Annual Income, $ -8,743 K
  • 60-Month Beta 0.66
  • Price/Sales 1.97
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AVCN.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings $-0.05 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3200 +18.75%
on 04/16/24
0.5500 -30.91%
on 04/01/24
-0.1300 (-25.49%)
since 03/22/24
3-Month
0.3000 +26.67%
on 01/30/24
0.6000 -36.67%
on 03/18/24
+0.0750 (+24.59%)
since 01/24/24
52-Week
0.2300 +65.22%
on 08/15/23
0.6000 -36.67%
on 03/18/24
unch (unch)
since 04/24/23

Most Recent Stories

More News
Stocks in play: Avicanna Inc.

Announced that the Company will host a medical symposium entitled “Cannabinoid-based Medicine in the ...

AVCN.TO : 0.3800 (-2.56%)
Stocks in play: Avicanna Inc.

Announced a corporate update and preliminary financial results of Q2-2023. Revenues were approximately ...

AVCN.TO : 0.3800 (-2.56%)
Stocks in play: Avicanna Inc

Announced the execution of the definitive Asset Purchase Agreement between Shoppers Drug Mart and Avicanna ...

AVCN.TO : 0.3800 (-2.56%)
Avicanna and Ei. Ventures Enter into an Agreement to Develop and Commercialize Adaptogen Nutraceuticals

Psilly™ branded functional fungi-based products will be developed by Avicanna utilizing Avicanna’s proprietary delivery systems and scientific platform ...

AVCN.TO : 0.3800 (-2.56%)
AVCNF : 0.3006 (+30.98%)
Avicanna Announces Date of Upcoming Annual General and Special Meeting of Shareholders

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.3800 (-2.56%)
AVCNF : 0.3006 (+30.98%)
Stocks in play: Avicanna Inc.

Has completed its first commercial export of its evidence-based derma-cosmetic line Pura H&W into the ...

AVCN.TO : 0.3800 (-2.56%)
Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

The company is maintaining operations and its shares in its primary Majority-Owned Subsidiary, Santa Marta Golden Hemp, also based in Santa Marta Colombia...

AVCN.TO : 0.3800 (-2.56%)
AVCNF : 0.3006 (+30.98%)
Avicanna’s Subsidiary Santa Marta Golden Hemp Completes First Commercial Export of Feminized Cannabis Seeds to Lesotho

This export marks the 16th international market entry for Avicanna and the first export of proprietary genetics into Africa. NOT FOR DISTRIBUTION TO...

AVCN.TO : 0.3800 (-2.56%)
AVCNF : 0.3006 (+30.98%)
Stocks in play: Avicanna Inc.

Announced that, through its majority owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH”), ...

AVCN.TO : 0.3800 (-2.56%)
Avicanna Subsidiary Santa Marta Golden Hemp S.A.S. Completes First Commercial Export of Aureus™ Branded THC and CBD Extracts to Portugal

This export marks Avicanna’s 15th international new market for Avicanna...

AVCN.TO : 0.3800 (-2.56%)
AVCNF : 0.3006 (+30.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid...

See More

Key Turning Points

3rd Resistance Point 0.4267
2nd Resistance Point 0.4133
1st Resistance Point 0.3967
Last Price 0.3800
1st Support Level 0.3667
2nd Support Level 0.3533
3rd Support Level 0.3367

See More

52-Week High 0.6000
Fibonacci 61.8% 0.4587
Fibonacci 50% 0.4150
Last Price 0.3800
Fibonacci 38.2% 0.3713
52-Week Low 0.2300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar